Literature DB >> 19076149

A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.

Umberto Capitanio1, Vincent Cloutier, Laurent Zini, Hendrik Isbarn, Claudio Jeldres, Shahrokh F Shariat, Paul Perrotte, Elie Antebi, Jean-Jacques Patard, Francesco Montorsi, Pierre I Karakiewicz.   

Abstract

OBJECTIVE To assess the magnitude of the effect of histological subtype (HS, the three most common being clear cell, papillary and chromophobe) on cause-specific mortality (CSM) from renal cell carcinoma (RCC). PATIENTS AND METHODS Univariable and multivariable Cox regression models included data from 11 618 patients treated with nephrectomy between 1988 and 2004 in nine Surveillance Epidemiology and End Results registries. We tested whether HS represents an independent predictor of CSM, and whether HS adds to the ability of other variables to predict CSM. The covariates comprised age, year of surgery, T stage, nodal status, M stage and Fuhrman grade. RESULTS In a multivariable model predicting CSM, HS was an independent predictor (P = 0.03), but failed to improve the accuracy of the model (+0.1% gain when HS was included in the model). CONCLUSION Although we confirmed that HS is an independent predictor for CSM, there was no gain in accuracy when HS was added to standard predictors of CSM. From a practical perspective, this implies that patients with clear cell, papillary and chromophobe HS share similar natural histories after nephrectomy, provided that other cancer characteristics are accounted for. From a statistical perspective, in multivariable models of CSM, the clear cell, papillary and chromophobe HS might be included as a single entity.

Entities:  

Mesh:

Year:  2008        PMID: 19076149     DOI: 10.1111/j.1464-410X.2008.08259.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  52 in total

Review 1.  Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Authors:  Juan I Martínez-Salamanca; Estefania Linares; Javier González; Roberto Bertini; Joaquín A Carballido; Thomas Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher P Evans; Paolo Gontero; Axel Haferkamp; Markus Hohenfellner; William C Huang; Theresa M Koppie; Viraj A Master; Rayan Matloob; James M McKiernan; Carrie M Mlynarczyk; Francesco Montorsi; Hao G Nguyen; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S Pruthi; Krishna Ramaswamy; Oscar Rodriguez Faba; Paul Russo; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Daniel Vergho; Eric M Wallen; Evanguelos Xylinas; Richard Zigeuner; John A Libertino
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

Review 2.  Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.

Authors:  Cedric Lebacle; Aydin Pooli; Thomas Bessede; Jacques Irani; Allan J Pantuck; Alexandra Drakaki
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

3.  [Clinical and pathological analysis of small renal cell carcinoma].

Authors:  X P Zhang; Z X Huang; L P Yu; X W Zhang; Q Li; S J Liu; T Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

4.  Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Authors:  Wong-Ho Chow; Brian Shuch; W Marston Linehan; Susan S Devesa
Journal:  Cancer       Date:  2012-11-12       Impact factor: 6.860

5.  An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Authors:  Mark P Purdue; Lee E Moore; Maria J Merino; Paolo Boffetta; Joanne S Colt; Kendra L Schwartz; Vladimir Bencko; Faith G Davis; Barry I Graubard; Vladimir Janout; Julie J Ruterbusch; Jennifer Beebe-Dimmer; Michele L Cote; Brian Shuch; Dana Mates; Jonathan N Hofmann; Lenka Foretova; Nathaniel Rothman; Neonilia Szeszenia-Dabrowska; Vsevolod Matveev; Sholom Wacholder; David Zaridze; W Marston Linehan; Paul Brennan; Wong-Ho Chow
Journal:  Int J Cancer       Date:  2013-01-15       Impact factor: 7.396

6.  Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma.

Authors:  Paolo Capogrosso; Alessandro Larcher; Daniel D Sjoberg; Emily A Vertosick; Francesco Cianflone; Paolo Dell'Oglio; Cristina Carenzi; Andrea Salonia; Andrew J Vickers; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  J Urol       Date:  2018-01-31       Impact factor: 7.450

7.  Impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy performed with the indication of renal cell carcinoma.

Authors:  Abdulmuttalip Şimşek; Onur Küçüktopcu; Fatih Akbulut; Faruk Özgör; Elif Küçüktopcu; Metin Savun; Yalçın Berberoğlu; Gökhan Gürbüz
Journal:  Turk J Urol       Date:  2015-03

8.  Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.

Authors:  Sandra Steffens; Frederik C Roos; Martin Janssen; Frank Becker; Julie Steinestel; Mahmoud Abbas; Konrad Steinestel; Gerd Wegener; Stefan Siemer; Joachim W Thüroff; Rainer Hofmann; Michael Stöckle; Mark Schrader; Arndt Hartmann; Kerstin Junker; Markus A Kuczyk; Andres J Schrader
Journal:  Virchows Arch       Date:  2014-09-02       Impact factor: 4.064

Review 9.  Follow-up after curative treatment of localised renal cell carcinoma.

Authors:  Saeed Dabestani; Lorenzo Marconi; Teele Kuusk; Axel Bex
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226

10.  Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system.

Authors:  Elizabeth P Weinzierl; Alan E Thong; Jesse K McKenney; Seung Hyun Jeon; Benjamin I Chung
Journal:  Korean J Urol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.